Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Researchers at the Harvard Medical School discovered that the enzyme GUK1 promotes lung cancer growth by boosting the ...

Because UHFR1 is implicated as an oncogene in numerous types of cancer, the results have implications for treating many cancers, say Baylin and Kong: "We are really excited about moving this ...

Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the rate of new cases continues to rise.

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

Researchers at the University of California at San Francisco have identified an RNA-binding protein that increased the ...

More than 70% of the known oncogenes and proto-oncogenes in cancer code for tyrosine kinases. Blocking tyrosine kinase activity therefore represents a rational approach to cancer therapy.

UC San Diego researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into oral cancer at the earliest stages of the disease ...

Preclinical analysis and clinical validation to identify biomarkers for trifluridine/tipiracil (FTD/TPI) efficacy with or without bevacizumab in patients with metastatic colorectal cancer. This is an ...

The newly-discovered TIMP1-CD63 signaling mechanism causes Kirsten rat sarcoma viral oncogene homologue (KRAS)-mutated cells found in about 90 percent of pancreatic cancer patients to evade ...